CVS Health Glycerin Suppositories, 100- count box, Distributed by:Distributed by: CVS Pharmacy, I...
FDA Drug Recall #D-1736-2019 — Class II — July 11, 2019
Recall Summary
| Recall Number | D-1736-2019 |
| Classification | Class II — Moderate risk |
| Date Initiated | July 11, 2019 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | US Pharmaceuticals Inc. |
| Location | Belleville, NJ |
| Product Type | Drugs |
| Quantity | 1174 cases |
Product Description
CVS Health Glycerin Suppositories, 100- count box, Distributed by:Distributed by: CVS Pharmacy, Inc. One CVS Drive Woonsocket, RI 02895. UPC 0 50428 42738 5
Reason for Recall
CGMP Deviations: Out of Specification results for either total microbial count or total organic carbon in the purified water utilized in the manufacturing process.
Distribution Pattern
Distributed Nationwide in the USA
Lot / Code Information
Lot #'s 61J17, 62J17, 65J17, 66J17, 67J17, 83J17, 86J17, 87J17 EXP 07/2019; Lot #'s 06P17, 08P17, 09P17, 10P17, 12P17, 13P17, 15P17, 16P17, 17P17, 18P17, 19P17, 21P17, 22P17, 23P17, 24P17 , 26P17 EXP 11/2019
Other Recalls from US Pharmaceuticals Inc.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| D-0113-2021 | Class II | CVS Health Hydrating Healing Ointment (Petrolat... | Nov 19, 2020 |
| D-1741-2019 | Class II | CRYO-273 Cold Pain Relieving Gel 128 FL. OZ. D... | Jul 11, 2019 |
| D-1730-2019 | Class II | Adult Glycerin Suppositories, Package Size 100-... | Jul 11, 2019 |
| D-1729-2019 | Class II | Adult Glycerin Suppositories, Package Size 50-c... | Jul 11, 2019 |
| D-1727-2019 | Class II | Children Glycerin Suppositories Laxative for ag... | Jul 11, 2019 |
Frequently Asked Questions
cGMP stands for Current Good Manufacturing Practice — the FDA's regulations governing drug manufacturing quality. A cGMP recall means the company failed to follow required manufacturing standards. This could involve inadequate testing, poor environmental controls, documentation failures, or process deviations. cGMP recalls do not always mean the product is directly harmful — in many cases, quality records are insufficient to confirm the product meets specifications. However, the FDA requires a recall because without proper documentation, product quality cannot be assured. These are often Class II or Class III recalls.
Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.
Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.
What Should You Do?
Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.